As prostate cancer progresses, it becomes increasingly aggressive and can metastasize. In this form, the tumor is difficult to treat, which is reflected in high mortality rates: Worldwide, the malignant disease of the prostate ...
Jun 5, 2024
0
10
Immunotherapy is based on harnessing a person's own immune system to attack cancer cells. However, patients with certain tumors do not respond to these therapies and it remains unclear why.
Jun 4, 2024
0
33
A large team of medical researchers and doctors has found via phase III clinical trial that the ALK inhibitor lorlatinib is highly effective for treating non–small cell lung cancer (NSCLC).
A novel immunotherapy approach developed by Ludwig Cancer Research scientists employs a two-pronged attack against solid tumors to boost the immune system's ability to target and eliminate cancer cells.
Jun 3, 2024
0
20
In a proof-of-concept study, researchers at the National Institutes of Health (NIH) have developed an artificial intelligence (AI) tool that uses routine clinical data, such as that from a simple blood test, to predict whether ...
Jun 3, 2024
0
19
In a new study, Yale researchers describe how a novel chemical compound attacks drug-resistant brain tumors without harming healthy surrounding tissue.
Jun 3, 2024
0
28
Researchers have revealed a new method to significantly enhance the efficacy of bispecific antibody therapies in treating solid tumors. Their findings were published on May 13 in Cell Reports Medicine.
May 31, 2024
0
21
A Stanford Medicine study of thousands of breast cancers has found that the gene sequences we inherit at conception are powerful predictors of the breast cancer type we might develop decades later and how deadly it might ...
May 30, 2024
0
31
Though 1 in 2 people will develop some form of cancer in their lifetime, there's still much we don't know about this disease. But thanks to continued research efforts, we keep learning more about the biology of cancer. One ...
May 30, 2024
0
213
The research group of Professor Riitta Lahesmaa have discovered a novel modulator for human regulatory T cells. This novel regulator can strengthen or dampen immune response and provides a new basis for therapeutic approaches ...
May 30, 2024
0
1
